Evaluation of Serum IL-7 as a Biomarker in Breast Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

December 1, 2026

Conditions
Breast Cancer
All Listed Sponsors
lead

Assiut University

OTHER